Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

What company makes Tylenol? Kimberly-Clark buys Kenvue in massive billion-dollar deal. Here's the who and what to know about other brands they own.

Kimberly-Clark, maker of Cottonelle and Scott toilet paper, Huggies and Kleenex tissues is buying Kenvue.  The purchase adds ...

Kenvue's fair value estimate has recently been adjusted from $22.13 to $21.70. This reflects analysts' tempered expectations in light of evolving industry dynamics. This shift comes as experts weigh ...

Kenvue (KVUE) shares have shown a mixed performance in recent weeks, with small daily moves resulting in a gradual decline over the past month. Investors are weighing the current momentum and ...

Kenvue offers stable financials, a robust 5% dividend yield, and the stock trades at a significant discount to peers and historical averages. KVUE's recent decline, driven by Tylenol-related headlines ...

Kenvue Inc. (NYSE:KVUE) is in a partnership with AI company Albert Invent to accelerate end-to-end R&D efforts across the company’s global portfolio of brands. The partnership is expected to enable ...

The consumer healthcare specialist has inherited a long-running legal controversy. It is facing its first lawsuit in the U.K. centered on a controversial product. Until it was spun off into a separate ...

Kenvue faces investor pressure amid strategic review, leadership changes and litigation risk Trump administration position on Tylenol erased $10 billion in market value Potential sale or spin-off of ...

Kenvue Inc., the world’s largest pure-play consumer health company, is navigating a complex landscape of challenges and opportunities following its spin-off from Johnson & Johnson. The company, known ...

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the ...